Author: Catherine M. Dentinger, FNP, MS; Brian J. McMahon, MD, MACP
Module updated - 2012-01-04
Author information and module status
Hepatitis A
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
What's New
ACP Members can access the full PIER website.

Newly Cited Reference2011-09-01
Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.
Newly Cited Reference2011-07-01
What factors determine the severity of hepatitis A-related acute liver failure?
Newly Cited Reference2010-11-08
The evolving epidemiology of hepatitis a in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007.
Newly Cited Reference2010-07-05
Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children.
Newly Cited Reference2010-07-02
Hepatitis A vaccination coverage among U.S. children aged 12-23 months - immunization information system sentinel sites, 2006-2009.
Newly Cited Reference2008-12-15
Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.
Newly Cited Reference2008-03-25
Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents.
FAQs
Brian J. McMahon, MD, MACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Catherine M. Dentinger, FNP, MS has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.